Salem Billan

7.3k total citations · 2 hit papers
66 papers, 3.1k citations indexed

About

Salem Billan is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Salem Billan has authored 66 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Surgery and 19 papers in Otorhinolaryngology. Recurrent topics in Salem Billan's work include Head and Neck Cancer Studies (19 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Salivary Gland Tumors Diagnosis and Treatment (9 papers). Salem Billan is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Salivary Gland Tumors Diagnosis and Treatment (9 papers). Salem Billan collaborates with scholars based in Israel, United States and Germany. Salem Billan's co-authors include Abraham Kuten, Roxolyana Abdah‐Bortnyak, Ulrike Tisch, Hossam Haick, Gang Peng, Yoav Y. Broza, Ziv Gil, Orit Kaidar‐Person, Meggie Hakim and Marwan Hakim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Nanotechnology.

In The Last Decade

Salem Billan

58 papers receiving 3.0k citations

Hit Papers

Diagnosing lung cancer in exhaled breath using gold nanop... 2009 2026 2014 2020 2009 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salem Billan Israel 20 1.7k 926 571 537 367 66 3.1k
Sung Hee Lim South Korea 31 1.3k 0.8× 613 0.7× 855 1.5× 1.1k 2.0× 391 1.1× 119 3.5k
Roxolyana Abdah‐Bortnyak Israel 11 1.6k 1.0× 910 1.0× 330 0.6× 71 0.1× 360 1.0× 28 2.1k
Shih‐Hao Huang Taiwan 23 546 0.3× 399 0.4× 569 1.0× 455 0.8× 29 0.1× 65 2.1k
Xianrang Song China 45 3.6k 2.1× 1.5k 1.6× 5.4k 9.5× 648 1.2× 171 0.5× 199 7.3k
Tian‐Lu Cheng Taiwan 41 763 0.5× 247 0.3× 2.1k 3.7× 987 1.8× 375 1.0× 161 4.8k
Rosa Terracciano Italy 31 334 0.2× 102 0.1× 727 1.3× 165 0.3× 250 0.7× 73 2.7k
Pengfei Rong China 39 2.6k 1.5× 163 0.2× 1.5k 2.6× 324 0.6× 61 0.2× 163 5.3k
Congjian Xu China 35 1.3k 0.7× 214 0.2× 2.1k 3.7× 755 1.4× 205 0.6× 158 4.9k
Keith A. Cengel United States 36 4.2k 2.5× 82 0.1× 1.4k 2.5× 929 1.7× 64 0.2× 193 8.0k
Peter M. Wilson United States 30 310 0.2× 478 0.5× 1.3k 2.2× 1.1k 2.0× 20 0.1× 59 3.2k

Countries citing papers authored by Salem Billan

Since Specialization
Citations

This map shows the geographic impact of Salem Billan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salem Billan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salem Billan more than expected).

Fields of papers citing papers by Salem Billan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salem Billan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salem Billan. The network helps show where Salem Billan may publish in the future.

Co-authorship network of co-authors of Salem Billan

This figure shows the co-authorship network connecting the top 25 collaborators of Salem Billan. A scholar is included among the top collaborators of Salem Billan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salem Billan. Salem Billan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Na’ara, Shorook, et al.. (2025). Evaluation and Outcomes of Iatrogenic Oropharyngeal Dysphagia. Clinical Otolaryngology. 50(4). 751–757.
2.
Billan, Salem, et al.. (2025). Comparative evaluation of symmetry, dosimetry, and toxicity in prostate cancer EBRT with spacing techniques. Frontiers in Oncology. 15. 1668726–1668726.
4.
Billan, Salem, et al.. (2024). Rectal spacer in radiotherapy for prostate cancer: Correlation of spacer symmetry to rectal dosimetry.. Journal of Clinical Oncology. 42(16_suppl). e17102–e17102. 1 indexed citations
6.
Bornstein, Jacob, et al.. (2024). Changing the paradigm: Elimination – Not only of cervical cancer. Gynecologic Oncology Reports. 54. 101445–101445.
7.
Muñoz‐Couselo, Eva, Brett Hughes, Laurent Mortier, et al.. (2024). Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study.. Journal of Clinical Oncology. 42(16_suppl). 9554–9554. 3 indexed citations
8.
Doweck, Ilana, Aron Popovtzer, Daniel Hendler, et al.. (2023). First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel. Frontiers in Oncology. 13. 1117804–1117804. 11 indexed citations
9.
Billan, Salem, et al.. (2023). A late presentation of inguinoscrotal cutaneous squamous cell carcinoma (cSCC) masquerading as hidradenitis suppurativa—a case report. Journal of Surgical Case Reports. 2023(8). rjad459–rjad459. 2 indexed citations
10.
Na’ara, Shorook, Abhishek Mukherjee, Salem Billan, & Ziv Gil. (2020). <p>Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma</p>. OncoTargets and Therapy. Volume 13. 2289–2298. 18 indexed citations
11.
Gil, Ziv, et al.. (2019). Developing an independent Palestinian cancer care capacity. The Lancet Oncology. 20(11). 1485–1486. 2 indexed citations
12.
Kaidar‐Person, Orit, Ziv Gil, & Salem Billan. (2018). Precision medicine in head and neck cancer. Drug Resistance Updates. 40. 13–16. 133 indexed citations
13.
Gil, Ziv, et al.. (2018). Building independence in health care and a partnership between nations. The Lancet Oncology. 19(7). 869–870. 3 indexed citations
14.
Kaidar‐Person, Orit, et al.. (2015). Toxicity of Treatment for Anal Carcinoma: 2D versus 3D Planning.. PubMed. 17(7). 414–7. 1 indexed citations
15.
Agbarya, Abed, et al.. (2014). Hormone dependent metastatic salivary gland carcinoma: a case report. SpringerPlus. 3(1). 363–363. 5 indexed citations
16.
Hakim, Marwan, Salem Billan, Ulrike Tisch, et al.. (2011). Diagnosis of head-and-neck cancer from exhaled breath. British Journal of Cancer. 104(10). 1649–1655. 170 indexed citations
17.
Meirovitz, Amichay, Salem Billan, Roxolyana Abdah‐Bortnyak, et al.. (2010). Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study. Radiation Oncology. 5(1). 16–16. 67 indexed citations
18.
Peng, Gang, Marwan Hakim, Yoav Y. Broza, et al.. (2010). Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. British Journal of Cancer. 103(4). 542–551. 604 indexed citations breakdown →
19.
Peng, Gang, Ulrike Tisch, Meggie Hakim, et al.. (2009). Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nature Nanotechnology. 4(10). 669–673. 1025 indexed citations breakdown →
20.
Kuten, Abraham, et al.. (2003). Neoadjuvant Radiotherapy Concurrent With Weekly Paclitaxel and Carboplatin and Followed by Surgery in Locally Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 26(2). 184–187. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026